Hoth Therapeutics, Inc. (HOTH) — 8-K Filings

8-K Filings (21)

• Hoth Therapeutics Files 8-K on Agreements and Equity Sales — Apr 2, 2026 Risk: medium
  Hoth Therapeutics, Inc. filed an 8-K on April 2, 2026, reporting on a material definitive agreement and unregistered sales of equity securities. The filing incl
• Hoth Therapeutics Files 8-K — Oct 17, 2025 Risk: low
  Hoth Therapeutics, Inc. filed an 8-K on October 17, 2025, reporting other events and financial statements. The filing does not contain specific financial figure
• Hoth Therapeutics Files 8-K: Other Events Reported — Sep 12, 2025 Risk: medium
  Hoth Therapeutics, Inc. filed an 8-K on September 12, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these eve
• Hoth Therapeutics Files 8-K on Officer/Director Changes — Aug 22, 2025 Risk: medium
  Hoth Therapeutics, Inc. filed an 8-K on August 20, 2025, reporting on the departure of directors or certain officers, election of directors, appointment of cert
• Hoth Therapeutics Files 8-K on Security Holder Vote Matters — Aug 5, 2025 Risk: low
  Hoth Therapeutics, Inc. filed an 8-K on August 5, 2025, to report on the submission of matters to a vote of its security holders. The filing does not contain sp
• 8-K Filing — Jun 24, 2025
• Hoth Therapeutics Files 8-K — Jun 20, 2025 Risk: low
  Hoth Therapeutics, Inc. filed an 8-K on June 20, 2025, reporting other events and financial statements as of June 18, 2025. The filing does not contain specific
• Hoth Therapeutics Files 8-K — Jun 9, 2025 Risk: low
  Hoth Therapeutics, Inc. filed an 8-K on June 9, 2025, reporting on other events and financial statements. The filing does not contain specific details about new
• Hoth Therapeutics Faces Delisting Concerns — May 16, 2025 Risk: high
  Hoth Therapeutics, Inc. filed an 8-K on May 16, 2025, reporting a notice of delisting or failure to satisfy continued listing rules. The filing indicates potent
• Hoth Therapeutics Files 8-K: Other Events — May 2, 2025 Risk: medium
  On May 2, 2025, Hoth Therapeutics, Inc. filed an 8-K report to disclose other events. The filing does not contain specific details about the nature of these eve
• Hoth Therapeutics Announces Board Changes and Officer Compensation — Apr 15, 2025 Risk: medium
  Hoth Therapeutics, Inc. announced on April 9, 2025, a change in its board of directors. Specifically, Dr. Robert L. Smith has been appointed as a new director,
• Hoth Therapeutics Files 8-K: Material Agreement & Financial Restatement — Mar 25, 2025 Risk: medium
  Hoth Therapeutics, Inc. filed an 8-K on March 25, 2025, reporting a material definitive agreement and a non-reliance on previously issued financial statements.
• Hoth Therapeutics Files 8-K — Feb 7, 2025 Risk: low
  Hoth Therapeutics, Inc. filed an 8-K on February 7, 2025, reporting other events and financial statements/exhibits. The filing does not contain specific financi
• Hoth Therapeutics Files 8-K — Jan 24, 2025 Risk: low
  Hoth Therapeutics, Inc. filed an 8-K on January 24, 2025, reporting on events that occurred on January 23, 2025. The filing primarily concerns other events and
• Hoth Therapeutics Amends Q3 2024 Financial Filing — Dec 2, 2024 Risk: low
  On December 2, 2024, Hoth Therapeutics, Inc. filed an 8-K report detailing an amendment to its previously filed Form 10-Q for the quarterly period ended Septemb
• Hoth Therapeutics Files 8-K — Nov 20, 2024 Risk: low
  Hoth Therapeutics, Inc. filed an 8-K on November 20, 2024, reporting other events and financial statements. The filing details the company's corporate structure
• Hoth Therapeutics Files 8-K — Nov 8, 2024 Risk: low
  Hoth Therapeutics, Inc. filed an 8-K on November 8, 2024, to report the entry into a material definitive agreement and to file financial statements and exhibits
• Hoth Therapeutics Faces Delisting Concerns — Nov 1, 2024 Risk: high
  Hoth Therapeutics, Inc. filed an 8-K on November 1, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The filing
• Hoth Therapeutics Files 8-K on Security Holder Votes — Aug 7, 2024 Risk: low
  Hoth Therapeutics, Inc. filed an 8-K on August 7, 2024, to report on matters submitted to a vote of security holders. The filing does not contain specific detai
• Hoth Therapeutics Relocates Executive Offices — Jun 17, 2024 Risk: low
  Hoth Therapeutics, Inc. filed an 8-K on June 17, 2024, reporting a change in its principal executive offices to 590 Madison Avenue, 21st Floor, New York, NY 100
• Hoth Therapeutics Files 8-K: Administrative Update, Nasdaq Listing Confirmed — Jan 9, 2024
  Hoth Therapeutics, Inc. filed an 8-K on January 9, 2024, reporting an 'Other Event' that occurred on January 8, 2024. This filing primarily serves to update adm

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX